WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009065296) GENE ENGINEERING IMMUNOREPRESSIVE POLYPEPTIDES AND THEIR PREPARING METHODS AND USES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/065296    International Application No.:    PCT/CN2008/001773
Publication Date: 28.05.2009 International Filing Date: 21.10.2008
Chapter 2 Demand Filed:    21.10.2008    
IPC:
C07K 14/435 (2006.01), C12N 15/12 (2006.01), C12N 15/64 (2006.01), A61K 38/17 (2006.01), A61P 19/00 (2006.01), A61P 37/06 (2006.01)
Applicants: LI, Wenxin [CN/CN]; (CN).
WU, Yingliang [CN/CN]; (CN).
CAO, Zhijian [CN/CN]; (CN).
HAN, Song [CN/CN]; (CN)
Inventors: LI, Wenxin; (CN).
WU, Yingliang; (CN).
CAO, Zhijian; (CN).
HAN, Song; (CN)
Agent: CHINA SCIENCE PATENT & TRADEMARK AGENT LTD; 25/F., Bldg. B Tsinghua Tongfang Hi-Tech Plaza No. 1, Wangzhuang Rd. Haidian District Beijing 100083 (CN)
Priority Data:
200710053679.0 30.10.2007 CN
Title (EN) GENE ENGINEERING IMMUNOREPRESSIVE POLYPEPTIDES AND THEIR PREPARING METHODS AND USES
(FR) POLYPEPTIDES IMMUNODÉPRESSEURS MODIFIÉS GÉNÉTIQUEMENT, LEURS PROCÉDÉS DE PRÉPARATION ET LEURS UTILISATIONS
(ZH) 基因工程免疫抑制多肽及制备方法和用途
Abstract: front page image
(EN)Provided are two gene engineering immunorepressive polypeptides whose amino acid sequences are shown in SEQ ID NO: 1 and SEQ ID NO: 2, respectively, and preparation methods thereof. Also provided are their uses for preparing pharmaceutical compositions for targeting potassium channel Kv1.3, treating or preventing multiple sclerosis and rheumatoid arthritis.
(FR)La présente invention concerne deux polypeptides immunodépresseurs modifiés génétiquement dont les séquences d'acides aminés sont montrées dans SEQ ID N° 1 et SEQ ID N° 2, respectivement, et leurs procédés de préparation. L'invention concerne également leur utilisation pour la préparation de compositions pharmaceutiques visant à cibler le canal potassique Kv1.3, à traiter ou prévenir la sclérose en plaque et la polyarthrite rhumatoïde.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)